6-ø glucose-6-phosphate  dehydrogenase
Janbonۺ֢ Janbon's  syndrome
PPBŨ parts per billion  concentration
pphmŨ parts per hundred million  concentration
PPHŨ parts per hundred  concentration
ppmŨ parts per million  concentration
ȫΧ safety  range
ȫ鷨 innocuity test  method
ȫϵͳ safety  coefficient
ο  placebo
ϼ chelating  agent
ϸ target  cell
׵΢Ƽ albumin  microballoons
ٷŨ percentage  concentration
ϳɿ semisynthetic  antibiotics
뿹ԭ  haptene
 half lethal dose ; median lethal dose;  LD50
˥ half-life period; half life  time
Ƭ coated  tablet
Һ saturated  solution
ն  Becquerel
 passive  immunity
ת passive  transport
  disintegration
  disintegrants
谱 essential  aminoacid
֬ essential fatty  acid
̬Ӧ allergy; allergic  reaction
 surface  activity
 surface  tension
 gamma  rays
Ĥ  film-coating
  complement
ϵͳ complement  system
Ӧ adverse  reaction
ȫԭ incomplete  antigen
  liniments
ڶʵ long term toxicity  test
ЧƼ prolonged action  preparation
ѭ enterohepatic  circulation
ܿƬ enteric controlled release  tablets
 enteric  coating
  prescription;recipe
͸ٽ penetration  enhancers
ԿƼ magnetic controlled release dosage  form
ҩƼ magnetic medicinal  preparations
  macromolecule
¡ monoclonal  antibody
ø  cholinesterase
 equivalent  weight
 equivalent  law
Ũ  normality
Һ normal  solution
Һ isotonic  solution
;  oligosaccharides
ܶ֬ low density  lipoprotein
ζ  titration
ζ titration  curve
  pill
  transmitter
  electrolyzation
  electrolyte
ѧ dispensing  pharmacy
  tincture
ҩƼ directed pharmaceutical  preparations
ѧ  toxicology
ԷӦ toxic response; toxic  reaction
°ʵ short term carcinogenic  test
 etiological  treatment
ӳ  antipode
֢ symptomatic  treatment
๦ø multifunctional  enzyme
ҩ multiple dose  administration
  polypeptide
  polyose
Ӱ  catecholamine
ظȾ  superinfection
  fermentation
 official  formula
廯 aromatic  compound
䶾ѧ  radiotoxicology
ҩѧ  radiopharmaceutics
Ǳ谱 non-essential amino  acid
ȥͼҩ  nondepolarizer
Ӳ molecular  disease
Һ molecular  solution
ѧ molecular  biology
ҩѧ molecular  pharmacology
 prosthetic  group
  excipients
ø  coenzyme
Ӽ  additive
 side  effect
 desiccant;drying  agent
׹ЧӦ first pass effect of  hepar
  receptor
  hyperreactivity
 individual differences; individual  variation
ҩҩٶ dosage regimen or dose  rate
ҩ dosing  interval
ҵҩѧ industrial  pharmacy
ۼ covalent  bond
 light  quantum
׿ broad-spectrum  antibiotic
  filtration
  anaphylatoxin
ҩﷴӦ anaphylactic drug  reaction
  superoxide
ȶ content  uniformity
ϲҩ drug  combination
ϳҩ synthetic  drugs
ϼ  mixture
  nucleotide
Ǻ ribonucleic acid;  RNA
Ԫ trace  element
ѧ chemical  analysis
ѧѧ chemical  physics
ѧ chemical  disinfection
ѧҩ  chemotherapy
ҩѧ environmental  pharmacology
ҩ essential  drugs
  gene
  activator
  activation
  hormone
ԭ  prohormone
Զʵ acute toxicity  test
Ǵϸ cytotoxic  hexitols
 dosage;  dose
Ũȵ dose or concentration  dependency
 dosage  form
° indirect  carcinogenesis
Ъ discontinuous  sterilization
ж  alkalosis;alkali-poisoning
Һҩ medical colloidal  solution
ͽ  glycolysis
׿  antagonism
ⶾ  detoxication
 mediator; transmitter;  medium
 psychic  dependence
ҩ powerful  drug
 absolute lethal dose;  LD100
Ƭ chewable  tablets
  antitoxin
 antibacterial  spectrum
  antibody
Ѫ  antiserum
ҩ resistance to  drugs
ԭ  antigen
˵ gram-equivalent  weight
˵ gram-equivalent  number
˷ gram-molecule;  gram-mol
˷ӷ molar  fraction
˷ gram molecular  weight
˷Ũ molar comcentratin; molal  comcentration
ԭ  gram-atom
Ƽ controlled release  preparation
ǻڸҩ oral  administration
  tachyphylaxis
ɢ  diffusion
ɢϵ coefficient of  diffusion
඾  anatoxin;toxoid
̴ͣҩۺ steroid withdrawal  syndrome
ۻй cumulative urinary excretion  curves
ۼЧӦ additive  effect
  cold-storage
䶳  freezing;refrigeration
ҩѧ quantum  pharmacology
ٴҩѧ clinical  pharmacology
ٴҩѧ chlinical  pharmacy
±  halogenide
ֲ  implants
ͨ slow  pathway
Զʵ chronic toxicity test; long term toxicity  test
ø  enzyme
øԭ  proenzyme
Ƽ immunosuppressant;immuno  inhibitor
ԭ  immunogenicity
ǿ  immunoenhancement
  sensitivity
Ħ  mole
ĦŨ mol fraction  concentration
Ħ molar volume;mole  volume
ĦŨ  molarity
Ĭ the Merck  index
ڶ  endotoxin
ڶԼⶨ Limulus Amebocyte Lysate assay for  endotoxin
  mesomer
  tolerance
ҩ drug  tolerance
Ũ  concentration
ƤճĤҩ skin and mucocutaneous  administration
ƬӲ tablet  hardness
  aerogel
ܽ  aerosol
 gas  analysis
  aerosol
ǰҩ  prodrug
ע intrathecal  injection
ȫø븨 holonzyme and prosthetic  group
˹ϳɿԭ artificial  antigen
˹ artificial  immunization
ҩѧ  ethnopharmacology
 Geneva  nomenclature
ܼ solvent;  dissolvent
ܽ dissolution;  dissolving
ܾø  lysozyme
Ѫ  hemolysis
  solute
ѭ tricarboxylic acid  cycle
ɱ bactericidal  activity
ɱ bactericidal  effect
 physical  dependence
񾭶  neurotoxin
 adrenergic  nerve
 adrenergic  receptor
͸ѹ osmotic  pressure
 growth  curve
ﰷ biogenic  amine
˥ biological half  life
ﻯѧ  biochemistry
  alkaloid
ö  bioavailability
ͳѧ  biometrics;biometry
ҩѧ  biopharmacy
Ʒ biological  product
ҩ crude  drugs
ʱҩѧ  chronopharmacology
ʱ  chronosusceptability
ʱ  chronotherapy
ʱЧϵ time-effect  relationship
ʱֵ  chronaxia;chronaxy
ʱ lag  time
֯ World Health Organization;  WHO
ɾ  bacteriophage
ҩ  astringent
ҩ chiral  drug
׹ЧӦ first-pass  effect
  receptor
弤 receptor  stimulant
׿ receptor  antagonist
˫ä double-blind  technique
ˮ⣨ã  hydrolysis
  gluconeogenesis
 body surface  area
Ũ volume by volume  concentration
Һ body  fluid
Һ humoral  immunity
Ȼ natural  antibody
Ȼԭ natural  antigen
Ȼ natural  immunity
Ȼҩ crude drugs; natural  drugs
ͬλ  isotope
ͻ  mutation
  phagocytosis
ⶾ  exotoxin
  raceme
ȫԭ complete  antigen
ˮ aqua regia; nitrohydrochloric  acid
΢ø microsomal  enzyme
΢Ԫ trace  element
̬ѪҩŨ steady state plasma  concentration
ҩѧ physical  pharmaceutics
뷨  inhalation
ʳ absorption rate  constant
ϸ cellular  immunity
Ծҩ restrictive  holagogue
 adenosine  phosphate
Ըҩ relative dosage  interval
 additive effect;  addition
иҩ targetable drug  delivery
ʳ elimination rate  constant
Ч  potency
Ч۵λ potency  unit
Чǿ  potency
ЧӦ  effect
ЧӦ  effector
ЧӦ  effector
Э cipher  prescription
Эͬ  synergism
˷  excitability
 sequential  design
Һ  suspension
ѡ  selectivity
Ѫڸҩ intravascular  administration
Ѫҩ extravascular  administration
Ѫ  plasma
ѪҺ plasma  substitute
Ѫ׽ plasma protein binding  ratio
Ѫ blood-cerebral  barrier
Ѫ  serum
Ѫ blood volume  expander
ѪҩŨ blood  concentration
ѪҺ blood  coagulation
ѪҺƷ blood  products
Ǽж subacute intoxication;subacute  poisoning
ж nitrite  poisoning
Ĥ ocular  inserts
ҩŨ peak concentration of  drug
ҩʱ peak time of  drug
ҩЧ pharmaceutical  equivalence
ҩѧ  pharmaceutics
ҩѧ  pharmacology
ҩ drug sensitive  test
ҩƷ allotted date of drug quality ensuring by  manufacturer
ҩƷ drug administration  law
ҩƷ drug batch  number
ҩƷʹ limit date of using a drug after its  production
ҩƷЧ expiry date; date of  expiration
ҩƷ׼ drug  standard
ҩ-ʱ semi-logarithmic curve of  drug-time
ҩ-ʱ drug-time  curve
ҩл drug  metabolism
ҩлø drug metablic  enzyme
ҩڹ intracorporal process of  drugs
ҩﶯѧģ pharmacokinetics  model
ҩﷴӦ drug  reaction
ҩֲ drug  distribution
ҩ pharmaceutical  analysis
ҩﻯѧ pharmaceutical  chemistry
ҩй drug  excretion
ҩ drug  absorption
ҩ໥ drug  interaction
ҩ drug  elimination
ҩ drug  accumulation
ҩѧ pharmacology; materia  medica
ҩŴѧ  pharmacogenetics
ҩЧѧ  pharmacodynamics
ҩѧʣ-Ӣ
ҩԴԼ drug-induced  diseases
  acetylcholine
ø  acetylcholinesterase
칹ø  isomerase
־ bacteriostatic  activity
־  bactriostasis
Ӫ  nutrient
Ӳ  plaster
Ч˥ effective  halt
Ч effective  rate
ЧŨ effective  concentration
  dextrose
 dextrorotatory  form
м threshold  dose
  carrier
߰  saponins
֬  liposome
ֱҩ rectal  administration
ֱ linear  correlation
ֽƬ oral medicaed soluble  paper
Ƽ  preparation
Ƽѧ technology of  pharmaceutics
ҩѧ pharmaceutical  chemistry
ƵЧֵ therapeutic  equivalence
 therapeutic  dose
ҩٲ therapeutic drug monitoring;  TDM
ָ therapeutic index  TI
 therapeutic  action
°ʵ carcinogenic  test
°  carcinogen
» teratogenic  test
»  teratogen
 sensitization  test
  sensitization
 fatal dose; lethal  dose
ж intoxication;  poisoning
л񹲺͹ҩƷ׼ Drug Standard of Ministry of Public Health of the People's Republic of  China
м  intermediate
˼ filter  aid
ܼ complex  solubilizer
 suspending  agent
  autoimmunity
鰷  histamine
ܼ maximal tolerable dose;  LDO
ü maxial noneffective dose;  EDO
С least significant  difference
СЧ minimal effective  dose
С minimal lethal  dose;MLD
  levulose
 levorotatory  form
  adjuvant
